The relevance of abnormalities in the distribution of peripheral blood
T lymphocyte subsets to the clinical manifestations of multiple scler
osis is not firmly established. A clinical and immunological follow-up
of relapsing-remitting multiple sclerosis patients was performed in o
rder to study the relationship of immune changes with the clinical cou
rse of the disease. Twenty patients were monitored monthly during a me
an time of nine months for peripheral blood lymphocyte subsets (CD3, C
D4, CD8, CD19), including the immunoregulatory subsets CD4CD29 (helper
-inducer), and CD4CD45RA (suppressor-inducer) and activated T helper c
ells (CD4CD25) by flow cytometry. A total of 14 untreated relapses was
included. The most significant observations were a decrease in T supp
ressor-inducer CD4(+)CD45RA(+) subset during clinical relapses (P = 0.
028) that was also detectable one month before (P = 0.020) and the lac
k of changes in CD4(+)CD29(+) and CD8(+) T cells. In addition, variati
ons in the percentage of CD4(+)CD25(+) activated T helper cells were n
ot associated with clinical exacerbations. These results indicate the
existence of a temporal association of immune changes in peripheral bl
ood, but not activation, with the clinical manifestations of multiple
sclerosis.